Skip to main content
Figure 1 | Italian Journal of Pediatrics

Figure 1

From: Resveratrol plus carboxymethyl-β-glucan in children with recurrent respiratory infections: a preliminary and real-life experience

Figure 1

Clinical data in control (Group A) and actively-treated (Group B) patients. A = number of days with nasal obstruction; B = number of days with rhinorrhea; C = number of days with sneezing; D = number of days with cough in Group A (control) and Group B (resveratrol plus carboxymethyl-β-glucan) assessed 30 days (T1), 60 days (T2), and 90 days (T3) after anti-infective and anti-inflammatory treatment.

Back to article page